TCL Archive In Brief: Moffitt Center Makes Major Recruitment Effort; Komen Foundation Invites Award Nominations May 28, 1993
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
